Characterizing the Impact of Presbyphonia on Social Interaction

Status: Recruiting
Location: See location...
Intervention Type: Other, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to determine if presbyphonia, or voice disorder caused by age-related change in the larynx, is associated with change in social interaction. This proposal investigates the impact of voice impairment in older adults on social interaction, loneliness, social disconnectedness, and depression. A series of questionnaires, voice assessments, and interviews will be performed to improve our understanding of how voice disorders affect older adults and how treatment of voice impairment with voice therapy may improve quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• Diagnosis of presbyphonia with findings of presbylaryngis on videostroboscopy, with findings of bilateral true vocal fold atrophy and normal vocal fold motion bilaterally

• Able to complete all questionnaires and voice assessment tasks

• Normal to mild hearing loss in aided condition (with hearing aids)

Locations
United States
Iowa
University of Iowa Hospitals & Clinics
RECRUITING
Iowa City
Contact Information
Primary
Matthew R Hoffman, MD, PhD
matthew-r-hoffman@uiowa.edu
319-356-2201
Backup
Emma L Thayer, BS
emma-thayer@uiowa.edu
319-678-7518
Time Frame
Start Date: 2025-01-10
Estimated Completion Date: 2026-08-31
Participants
Target number of participants: 25
Treatments
Experimental: Phonation Resistance Training Exercises (PhoRTE) Voice Therapy Program
PhoRTE is a voice therapy program administered by a speech language pathologist for participants with presbyphonia. During sessions, participants perform five vocal exercises at individualized target vocal intensity. Goals of therapy are to increase muscular workload on vocal mechanism and target the respiratory and laryngeal muscular deficits that result from aging. Participants practice 6 days per week at home and meet with speech pathologist weekly for 4 weeks.
Related Therapeutic Areas
Sponsors
Leads: Matthew R. Hoffman

This content was sourced from clinicaltrials.gov